Your browser doesn't support javascript.
loading
International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer.
Vassal, Gilles; Houghton, Peter J; Pfister, Stefan M; Smith, Malcolm A; Caron, Huib N; Li, Xiao-Nan; Shields, David J; Witt, Olaf; Molenaar, Jan J; Colombetti, Sara; Schüler, Julia; Stancato, Lou F.
Affiliation
  • Vassal G; Institute Gustave Roussy, Université Paris Saclay, Villejuif, France. gilles.vassal@gustaveroussy.fr.
  • Houghton PJ; Greehey Children's Cancer Research Institute, UT Health, San Antonio, Texas.
  • Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) and University Hospital, Heidelberg, Germany.
  • Smith MA; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland.
  • Caron HN; Hoffmann-La Roche, Basel, Switzerland.
  • Li XN; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
  • Shields DJ; Pfizer Centers for Therapeutic Innovation, Pfizer Inc., New York, New York.
  • Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) and University Hospital, Heidelberg, Germany.
  • Molenaar JJ; Princess Máxima Centrum for Pediatric Oncology, Utrecht, The Netherlands.
  • Colombetti S; Hoffmann-La Roche, Basel, Switzerland.
  • Schüler J; Charles River Discovery Research Services Germany, Freiburg, Germany.
  • Stancato LF; Eli Lilly and Company, Indianapolis, Indiana.
Mol Cancer Ther ; 20(8): 1462-1468, 2021 08.
Article in En | MEDLINE | ID: mdl-34108262
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Therapies, Investigational / Disease Models, Animal / Drug Evaluation, Preclinical / Neoplasms / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Adolescent / Animals / Child / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2021 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Therapies, Investigational / Disease Models, Animal / Drug Evaluation, Preclinical / Neoplasms / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Adolescent / Animals / Child / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2021 Document type: Article Affiliation country: France Country of publication: United States